Amanda C. Guidon

3.6k total citations
44 papers, 1.2k citations indexed

About

Amanda C. Guidon is a scholar working on Neurology, Oncology and Genetics. According to data from OpenAlex, Amanda C. Guidon has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 16 papers in Oncology and 9 papers in Genetics. Recurrent topics in Amanda C. Guidon's work include Myasthenia Gravis and Thymoma (20 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Peripheral Neuropathies and Disorders (12 papers). Amanda C. Guidon is often cited by papers focused on Myasthenia Gravis and Thymoma (20 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Peripheral Neuropathies and Disorders (12 papers). Amanda C. Guidon collaborates with scholars based in United States, Spain and Italy. Amanda C. Guidon's co-authors include Anthony A. Amato, Kerry L. Reynolds, William S. David, Ryan J. Sullivan, Justine V. Cohen, Meghan J. Mooradian, Nathan F. Clement, Donald F. Chute, Donald P. Lawrence and Divyanshu Dubey and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Neurology.

In The Last Decade

Amanda C. Guidon

40 papers receiving 1.1k citations

Peers

Countries citing papers authored by Amanda C. Guidon

Since Specialization

Citations

This map shows the geographic impact of Amanda C. Guidon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda C. Guidon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda C. Guidon more than expected).

Fields of papers citing papers by Amanda C. Guidon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda C. Guidon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda C. Guidon. The network helps show where Amanda C. Guidon may publish in the future.

Co-authorship network of co-authors of Amanda C. Guidon

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda C. Guidon. A scholar is included among the top collaborators of Amanda C. Guidon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda C. Guidon. Amanda C. Guidon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States 2024 ·Neurology Clinical Practice ·(unknown), Leah Zuroff, Amanda C. Guidon, Grant T. Liu, Shawn J. Bird, Sunil Singhal, Gil I. Wolfe, Ali G. Hamedani	1
2	Peripheral nervous system immune-related adverse events due to checkpoint inhibition 2024 ·Nature Reviews Neurology ·M.J. O’Hare, Amanda C. Guidon	17
3	Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination 2024 ·Frontiers in Neurology ·Marc Garbey, (unknown), (unknown), (unknown), (unknown), Amanda C. Guidon, Vern C. Juel, Richard J. Nowak, (unknown), Inmaculada Aban, Henry J. Kaminski	5
4	Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes 2023 ·The Lancet Neurology ·Antonio Farina, Macarena Villagrán‐García, Alberto Vogrig, Αναστασία Ζεκερίδου, Sergio Muñiz‐Castrillo, Roser Velasco, Amanda C. Guidon, Bastien Joubert, Jérôme Honnorat	53
5	The Neuromuscular Portal and Match 2023 ·PubMed ·Ruple S. Laughlin, (unknown), (unknown), (unknown), Karissa Gable, Raghav Govindarajan, Amanda C. Guidon, Kelly Gwathmey, Michael K. Hehir, (unknown), Raymond S. Price, Sarada Sakamuri, (unknown), (unknown), (unknown), Zachary London	0
6	Immune Checkpoint Inhibitor Rechallenge Following Neurologic Immune-Related Adverse Events in Cancer Patients: A Systematic Review (P8-1.002) 2022 ·Neurology ·Mahsa Eskian, Balwant Singh, Leyre Zubiri, (unknown), Lisa Philpotts, Kerry L. Reynolds, Amanda C. Guidon	1
7	The neuromuscular fellowship portal and match 2022 ·Muscle & Nerve ·Zachary London, Karissa Gable, (unknown), Amanda C. Guidon, Kelly Gwathmey, Michael K. Hehir, (unknown), Ruple S. Laughlin, Raymond S. Price, Sarada Sakamuri, (unknown), (unknown)	3
8	A review of neurotoxicities associated with immunotherapy and a framework for evaluation 2021 ·Neuro-Oncology Advances ·(unknown), Mahsa Eskian, Amanda C. Guidon, Kerry L. Reynolds	15
9	Case Report of Lambert Eaton Myasthenic Syndrome in a Patient with Small Cell Lung Cancer on Immune Checkpoint Inhibitor Therapy 2021 ·OBM Neurobiology ·Collin J. Anderson, Amanda C. Guidon, (unknown), Alissa A. Thomas, (unknown), Michael K. Hehir, Noah Kolb	0
10	Case Report of Lambert Eaton Myasthenic Syndrome in a Patient with Small Cell Lung Cancer on Immune Checkpoint Inhibitor Therapy 2021 ·OBM Neurobiology ·Collin J. Anderson, Amanda C. Guidon, (unknown), Alissa A. Thomas, (unknown), Michael K. Hehir, Noah Kolb	11
11	Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum 2020 ·Annals of Neurology ·Divyanshu Dubey, William S. David, Kerry L. Reynolds, Donald F. Chute, Nathan F. Clement, Justine V. Cohen, Donald P. Lawrence, Meghan J. Mooradian, Ryan J. Sullivan, Amanda C. Guidon	151
12	Immune checkpoint inhibitor related neurologic adverse events: clinical spectrum, management and outcomes (S21.003) 2019 ·Neurology ·Divyanshu Dubey, William David, Kerry L. Reynolds, Donald F. Chute, Nathan F. Clement, Justine V. Cohen, Donald P. Lawrence, Meghan J. Mooradian, Ryan J. Sullivan, Amanda C. Guidon	2
13	Lambert-Eaton Myasthenic Syndrome, Botulism, and Immune Checkpoint Inhibitor–Related Myasthenia Gravis 2019 ·CONTINUUM Lifelong Learning in Neurology ·Amanda C. Guidon	20
14	Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies 2019 ·Neurology ·Divyanshu Dubey, William S. David, Anthony A. Amato, Kerry L. Reynolds, Nathan F. Clement, Donald F. Chute, Justine V. Cohen, Donald P. Lawrence, Meghan J. Mooradian, Ryan J. Sullivan, Amanda C. Guidon	111
15	Rituximab desensitization in two patients with muscle‐specific kinase myasthenia gravis 2019 ·Muscle & Nerve ·(unknown), (unknown), Aidan A. Long, Amanda C. Guidon	1
16	Characterization of B cells in muscle-specific kinase antibody myasthenia gravis 2015 ·Neurology Neuroimmunology & Neuroinflammation ·Jeffrey T. Guptill, John S. Yi, Donald B. Sanders, Amanda C. Guidon, Vern C. Juel, Janice M. Massey, James F. Howard, Flavia Scuderi, Emanuela Bartoccioni, Amelia Evoli, Kent J. Weinhold	51
17	Neuromuscular Ultrasound Findings in Eosinophilic Fasciitis (P6.087) 2014 ·Neurology ·(unknown), Lisa D. Hobson‐Webb, (unknown), Amanda C. Guidon, (unknown), Michael S. Cartwright	1
18	Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis 2014 ·Journal of Autoimmunity ·John S. Yi, Amanda C. Guidon, (unknown), (unknown), Vern C. Juel, Janice M. Massey, Donald B. Sanders, Kent J. Weinhold, Jeffrey T. Guptill	58
19	Neuromuscular Disorders in Pregnancy 2012 ·Neurologic Clinics ·Amanda C. Guidon, E. Wayne Massey	20
20	A Retrospective study of complications of therapeutic plasma exchange in myasthenia 2012 ·Muscle & Nerve ·Jeffrey T. Guptill, (unknown), Maragatha Kuchibhatla, Amanda C. Guidon, Lisa D. Hobson‐Webb, Janice M. Massey, Donald B. Sanders, Vern C. Juel	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact